Protara Therapeutics (TARA) Non-cash Items (2016 - 2026)

Protara Therapeutics' Non-cash Items history spans 14 years, with the latest figure at $8.8 million for Q1 2026.

  • Quarterly Non-cash Items rose 109.33% to $8.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Mar 2026, up 109.33% year-over-year, with the annual reading at $9.0 million for FY2025, 0.0% changed from the prior year.
  • Non-cash Items came in at $8.8 million for Q1 2026, down from $9.0 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $9.0 million in Q4 2024 to a low of $20000.0 in Q4 2023.
  • The 5-year median for Non-cash Items is $1.3 million (2025), against an average of $3.1 million.
  • Year-over-year, Non-cash Items skyrocketed 5993820.63% in 2022 and then tumbled 97.35% in 2023.
  • Protara Therapeutics' Non-cash Items stood at $755234.0 in 2022, then crashed by 97.35% to $20000.0 in 2023, then soared by 44810.0% to $9.0 million in 2024, then changed by 0.0% to $9.0 million in 2025, then fell by 1.56% to $8.8 million in 2026.
  • Per Business Quant, the three most recent readings for TARA's Non-cash Items are $8.8 million (Q1 2026), $9.0 million (Q4 2025), and $5.0 million (Q3 2025).